Related Experiment Video
Updated: Feb 11, 2026

08:09
Methionine Functionalized Biocompatible Block Copolymers for Targeted Plasmid DNA Delivery
Published on: August 6, 2019
6.2K
Exploiting methionine restriction for cancer treatment
Sushma Chaturvedi1, Robert M Hoffman2, Joseph R Bertino1
1Rutgers Cancer Institute of New Jersey, USA.
Biochemical Pharmacology
|May 8, 2018
Summary
Methionine restriction shows promise for cancer treatment by targeting tumors that depend on external methionine for survival. This dietary or enzymatic approach, alone or with chemotherapy, offers a novel antitumor strategy.
Area of Science:
- Oncology
- Nutritional Biochemistry
- Cancer Metabolism
Background:
- Normal cells produce methionine, but many cancers require external sources.
- Methionine dependence is a vulnerability in cancer cells.
- Methylthioadenosine phosphorylase (MTAP) deficiency is linked to methionine dependence, but other causes exist.
Purpose of the Study:
- To review studies on methionine restriction as a cancer treatment.
- To explore the basis of methionine dependence in tumors.
- To evaluate methionine restriction combined with other therapies.
Main Methods:
- Dietary methionine restriction in preclinical models.
- Enzyme depletion strategies targeting methionine metabolism.
- Combination therapy with chemotherapeutics.
- Review of existing literature on cancer methionine dependence.
Main Results:
- Methionine restriction, via diet or enzyme depletion, demonstrates antitumor effects.
- Combining methionine restriction with chemotherapy enhances efficacy.
- Understanding the mechanisms of methionine dependence is crucial for treatment development.
Conclusions:
- Methionine restriction is a viable and promising strategy for treating specific cancers.
- Targeting cancer's methionine dependency offers a novel therapeutic avenue.
- Further research into methionine metabolism in cancer is warranted.
Related Concept Videos
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Restriction Enzymes
36.3K
Restriction enzymes are bacterial enzymes used to cut DNA in a sequence-specific manner. To cleave DNA, they bind to specific palindromic sequences called restriction sites. Such palindromic DNA sequences or inverted repeats are commonly found in regions of functional significance, such as the origin of replication, gene operator sites, and regions containing transcription termination signals.
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
The host bacteria protect their own genomic DNA from these enzymes by methylating these sites. Some...
36.3K
Cardiomyopathy IV: Restrictive Cardiomyopathy
583
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
583
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
546
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
546
Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
Cancer
54.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.4K

